-
1
-
-
70449369312
-
Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis
-
Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer 2009; 115:5349-5361.
-
(2009)
Cancer
, vol.115
, pp. 5349-5361
-
-
Satin, J.R.1
Linden, W.2
Phillips, M.J.3
-
2
-
-
78650303467
-
Depression and cancer mortality: A meta-analysis
-
Pinquart M, Duberstein PR. Depression and cancer mortality: A meta-analysis. Psychol Med 2010;40:1797-1810.
-
(2010)
Psychol Med
, vol.40
, pp. 1797-1810
-
-
Pinquart, M.1
Duberstein, P.R.2
-
3
-
-
33746851955
-
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
-
Thaker PH, Han LY, Kamat AA et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 2006;12:939-944.
-
(2006)
Nat Med
, vol.12
, pp. 939-944
-
-
Thaker, P.H.1
Han, L.Y.2
Kamat, A.A.3
-
4
-
-
4644292447
-
Stress, depression, the immune system, and cancer
-
Reiche EMV, Nunes SOV, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-625.
-
(2004)
Lancet Oncol
, vol.5
, pp. 617-625
-
-
Reiche, E.M.V.1
Nunes, S.O.V.2
Morimoto, H.K.3
-
5
-
-
43449129458
-
Depression after diagnosis of advanced non-small cell lung cancer and survival: A pilot study
-
Pirl WF, Temel JS, Billings A et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: A pilot study. Psychosomatics 2008;49:218-224.
-
(2008)
Psychosomatics
, vol.49
, pp. 218-224
-
-
Pirl, W.F.1
Temel, J.S.2
Billings, A.3
-
6
-
-
2342471392
-
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
-
Lynch TJ, Bell DW, Sordella R et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 2004;350:2129-2139.
-
(2004)
N Engl J Med
, vol.350
, pp. 2129-2139
-
-
Lynch, T.J.1
Bell, D.W.2
Sordella, R.3
-
7
-
-
45149084723
-
First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations
-
Sequist LV, Martins RG, Spigel D et al. First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations. J Clin Oncol 2008;26:2442-2449.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2442-2449
-
-
Sequist, L.V.1
Martins, R.G.2
Spigel, D.3
-
8
-
-
69349088824
-
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: Results of an online tumor registry of clinical trials
-
Jackman DM, Miller VA, Cioffredi LA et al. Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: Results of an online tumor registry of clinical trials. Clin Cancer Res 2009;15:5267-5273.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5267-5273
-
-
Jackman, D.M.1
Miller, V.A.2
Cioffredi, L.A.3
-
9
-
-
70349758654
-
Activating mutations within the EGFR ki-nase domain: A molecular predictor of disease-free survival in resected pulmonary adenocarcinoma
-
Lee YJ, Park IK, Park MS et al. Activating mutations within the EGFR ki-nase domain: A molecular predictor of disease-free survival in resected pulmonary adenocarcinoma. J Cancer Res Clin Oncol 2009;135:1647-1654.
-
(2009)
J Cancer Res Clin Oncol
, vol.135
, pp. 1647-1654
-
-
Lee, Y.J.1
Park, I.K.2
Park, M.S.3
-
10
-
-
75749131958
-
EGFR mutations are associated with prognosis but not with the response to first-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer
-
Wu M, Zhao J, Song SW et al. EGFR mutations are associated with prognosis but not with the response to first-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer. Lung Cancer 2010;67: 343-347.
-
(2010)
Lung Cancer
, vol.67
, pp. 343-347
-
-
Wu, M.1
Zhao, J.2
Song, S.W.3
-
11
-
-
67949114283
-
Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue
-
Aouizerat BE, Dodd M, Lee K et al. Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 2009;11:27-41.
-
(2009)
Biol Res Nurs
, vol.11
, pp. 27-41
-
-
Aouizerat, B.E.1
Dodd, M.2
Lee, K.3
-
12
-
-
52949090015
-
Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings
-
Collado-Hidalgo A, Bower JE, Ganz PA et al. Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings. Brain Behav Immun 2008;22:1197-1200.
-
(2008)
Brain Behav Immun
, vol.22
, pp. 1197-1200
-
-
Collado-Hidalgo, A.1
Bower, J.E.2
Ganz, P.A.3
-
13
-
-
47849090505
-
Molecular epidemiology, cancer-related symptoms, and cytokines pathway
-
Reyes-Gibby CC, Wu X, Spitz M et al. Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 2008;9:777-785.
-
(2008)
Lancet Oncol
, vol.9
, pp. 777-785
-
-
Reyes-Gibby, C.C.1
Wu, X.2
Spitz, M.3
-
14
-
-
80053212322
-
The cancer anorexia/weight loss syndrome: Exploring associations with single nucleotide polymorphism (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer
-
Jatoi A, Qi Y, Kendall G et al. The cancer anorexia/weight loss syndrome: Exploring associations with single nucleotide polymorphism (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Support Care Cancer 2010;18:1299-1304.
-
(2010)
Support Care Cancer
, vol.18
, pp. 1299-1304
-
-
Jatoi, A.1
Qi, Y.2
Kendall, G.3
-
15
-
-
20044364940
-
Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers
-
Shigematsu H, Lin L, Takahashi T et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 2005;97:339-346.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 339-346
-
-
Shigematsu, H.1
Lin, L.2
Takahashi, T.3
-
16
-
-
0033544340
-
Validation and utility of a self report version of PRIME-MD: The PHQ primary care study
-
Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self report version of PRIME-MD: The PHQ primary care study. JAMA 1999; 282:1737-1744.
-
(1999)
JAMA
, vol.282
, pp. 1737-1744
-
-
Spitzer, R.L.1
Kroenke, K.2
Williams, J.B.W.3
-
17
-
-
52449118813
-
Randomized controlled trial of collaborative care management of depression among low-income patients with cancer
-
Ell K, Xie B, Quon B et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 2008;26:4488-4496.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4488-4496
-
-
Ell, K.1
Xie, B.2
Quon, B.3
-
18
-
-
64249136379
-
Depression screening using the Patient Health Questionnaire-9 administeredonatouch screen computer
-
Fann JR, Berry DL, Wolpin S et al. Depression screening using the Patient Health Questionnaire-9 administeredonatouch screen computer. Psycoon-cology 2009;18:14-22.
-
(2009)
Psycoon-cology
, vol.18
, pp. 14-22
-
-
Fann, J.R.1
Berry, D.L.2
Wolpin, S.3
-
19
-
-
0034853189
-
The PHQ-9: Validity of a brief depression severity measure
-
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613.
-
(2001)
J Gen Intern Med
, vol.16
, pp. 606-613
-
-
Kroenke, K.1
Spitzer, R.L.2
Williams, J.B.3
-
20
-
-
29544444953
-
Responsiveness of the PHQ-9 to psychopharmacological depression treatment
-
Löwe B, Schenkel I, Carney-Doebbeling C et al. Responsiveness of the PHQ-9 to psychopharmacological depression treatment. Psychosomatics 2006;47:62-67.
-
(2006)
Psychosomatics
, vol.47
, pp. 62-67
-
-
Löwe, B.1
Schenkel, I.2
Carney-Doebbeling, C.3
-
21
-
-
69349083935
-
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population
-
Rodig SJ, Mino-Kenudson M, Dacic S et al. Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population. Clin Cancer Res 2009;15:5216-5223.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 5216-5223
-
-
Rodig, S.J.1
Mino-Kenudson, M.2
Dacic, S.3
-
22
-
-
65249095599
-
The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS
-
Wong DW, Leung EL, So KK et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 2009;115:1723-1733.
-
(2009)
Cancer
, vol.115
, pp. 1723-1733
-
-
Wong, D.W.1
Leung, E.L.2
So, K.K.3
-
23
-
-
0020396015
-
Toxicity and response criteria of the Eastern Cooperative Oncology Group
-
Oken MM, Creech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649- 655.
-
(1982)
Am J Clin Oncol
, vol.5
, pp. 649-655
-
-
Oken, M.M.1
Creech, R.H.2
Tormey, D.C.3
-
24
-
-
0029042825
-
Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
-
Cella DF, Bonomi AE, Lloyd SR et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 1995;12:199-220.
-
(1995)
Lung Cancer
, vol.12
, pp. 199-220
-
-
Cella, D.F.1
Bonomi, A.E.2
Lloyd, S.R.3
-
25
-
-
10844231985
-
Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications
-
Kosaka T, Yatabe Y, Endoh H et al. Mutations of the epidermal growth factor receptor gene in lung cancer: Biological and clinical implications. Cancer Res 2004;64:8919-8923.
-
(2004)
Cancer Res
, vol.64
, pp. 8919-8923
-
-
Kosaka, T.1
Yatabe, Y.2
Endoh, H.3
-
26
-
-
3042740806
-
High levels of untreated distress and fatigue in cancer patients
-
Carlson LE, Angen M, Cullum J et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer 2004;90:2297-2304.
-
(2004)
Br J Cancer
, vol.90
, pp. 2297-2304
-
-
Carlson, L.E.1
Angen, M.2
Cullum, J.3
-
27
-
-
0035137365
-
Physical functioning and depression among older persons with cancer
-
Kurtz ME, Kurtz JC, Stommel M, et al. Physical functioning and depression among older persons with cancer. Cancer Pract 2001;9:11-18.
-
(2001)
Cancer Pract
, vol.9
, pp. 11-18
-
-
Kurtz, M.E.1
Kurtz, J.C.2
Stommel, M.3
-
28
-
-
45849142970
-
Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer
-
LoConte NK, Else-Quest NM, Eickhoff J et al. Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer. Clin Lung Cancer 2008;9:171-178.
-
(2008)
Clin Lung Cancer
, vol.9
, pp. 171-178
-
-
Loconte, N.K.1
Else-Quest, N.M.2
Eickhoff, J.3
-
30
-
-
0034893542
-
Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings
-
Musselman DL, Miller AH, Porter MR et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. Am J Psychiatry 2001;158:1252-1257.
-
(2001)
Am J Psychiatry
, vol.158
, pp. 1252-1257
-
-
Musselman, D.L.1
Miller, A.H.2
Porter, M.R.3
-
31
-
-
46049102610
-
Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients
-
Lutgendorf SK, Lamkin DM, DeGeest K et al. Depressed and anxious mood and T-cell cytokine expressing populations in ovarian cancer patients. Brain Behav Immun 2008;22:890-900.
-
(2008)
Brain Behav Immun
, vol.22
, pp. 890-900
-
-
Lutgendorf, S.K.1
Lamkin, D.M.2
Degeest, K.3
-
32
-
-
0029844934
-
Elevated lung cancer risk among persons with depressed mood
-
Knekt P, Raitasalo R, Heliövaara M et al. Elevated lung cancer risk among persons with depressed mood. Am J Epidemiol 1996;144:1096-1103.
-
(1996)
Am J Epidemiol
, vol.144
, pp. 1096-1103
-
-
Knekt, P.1
Raitasalo, R.2
Heliövaara, M.3
-
33
-
-
77950689861
-
Depression and cancer risk: 24 years of follow-upof the Baltimore Epidemiologic Catchment Area sample
-
Gross AL, Gallo JJ, Eaton WW. Depression and cancer risk: 24 years of follow-upof the Baltimore Epidemiologic Catchment Area sample. Cancer Causes Control 2010;21:191-199.
-
(2010)
Cancer Causes Control
, vol.21
, pp. 191-199
-
-
Gross, A.L.1
Gallo, J.J.2
Eaton, W.W.3
-
34
-
-
33748445361
-
Symptom improvement in lung cancer patients treated with erlotinib: Quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21
-
Bezjak A, Tu D, Seymour L et al. Symptom improvement in lung cancer patients treated with erlotinib: Quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 2006;24:3831-3837.
-
(2006)
J Clin Oncol
, vol.24
, pp. 3831-3837
-
-
Bezjak, A.1
Tu, D.2
Seymour, L.3
-
35
-
-
34250192263
-
Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis
-
Rich TA. Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis. J Support Oncol 2007;5:167-174.
-
(2007)
J Support Oncol
, vol.5
, pp. 167-174
-
-
Rich, T.A.1
-
36
-
-
59649119755
-
Behavioral effects of systemic transforming growth factor-alpha in Syrian hamsters
-
Gilbert J, Davis FC. Behavioral effects of systemic transforming growth factor-alpha in Syrian hamsters. Behav Brain Res 2009;198:440-448.
-
(2009)
Behav Brain Res
, vol.198
, pp. 440-448
-
-
Gilbert, J.1
Davis, F.C.2
-
37
-
-
16344373564
-
Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer
-
Rich T, Innominato PF, Boerner J et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005;11:1757-1763.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1757-1763
-
-
Rich, T.1
Innominato, P.F.2
Boerner, J.3
-
38
-
-
79951911113
-
Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21
-
Addison CL, Ding K, Zhao H et al. Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21. J Clin Oncol 2010;28:5247-5256.
-
(2010)
J Clin Oncol
, vol.28
, pp. 5247-5256
-
-
Addison, C.L.1
Ding, K.2
Zhao, H.3
-
39
-
-
78650504769
-
Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomark-ers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer
-
Vollebergh MA, Kappers I, Klomp HM et al. Ligands of epidermal growth factor receptor and the insulin-like growth factor family as serum biomark-ers for response to epidermal growth factor receptor inhibitors in patients with advanced non-small cell lung cancer. J Thorac Oncol 2010;5:1939-1948.
-
(2010)
J Thorac Oncol
, vol.5
, pp. 1939-1948
-
-
Vollebergh, M.A.1
Kappers, I.2
Klomp, H.M.3
-
40
-
-
34249907598
-
Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/ immunological responses both in vivo and in vitro
-
Fukuyama T, Ichiki Y, Yamada S et al. Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/ immunological responses both in vivo and in vitro. Cancer Sci 2007;98: 1048-1054.
-
(2007)
Cancer Sci
, vol.98
, pp. 1048-1054
-
-
Fukuyama, T.1
Ichiki, Y.2
Yamada, S.3
-
41
-
-
55449123441
-
Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor somatic mutation in patients with advanced non-squa-mous, non-small cell lung cancer
-
Masago K, Fujita S, Hatachi Y et al. Clinical significance of pretreatment serum amphiregulin and transforming growth factor-alpha, and an epidermal growth factor somatic mutation in patients with advanced non-squa-mous, non-small cell lung cancer. Cancer Sci 2008;99:2295-2301.
-
(2008)
Cancer Sci
, vol.99
, pp. 2295-2301
-
-
Masago, K.1
Fujita, S.2
Hatachi, Y.3
-
42
-
-
34548802504
-
Epidermal growth factor ligand/ receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer
-
Volante M, Saviozzi S, Rapa I et al. Epidermal growth factor ligand/ receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer. Cancer 2007;110:1321-1328.
-
(2007)
Cancer
, vol.110
, pp. 1321-1328
-
-
Volante, M.1
Saviozzi, S.2
Rapa, I.3
-
43
-
-
58149265465
-
Autocrine production of am-phiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers
-
Yonesaka K, Zejnullahu K, Lindeman N et al. Autocrine production of am-phiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers. Clin Cancer Res 2008;14:6963-6973.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 6963-6973
-
-
Yonesaka, K.1
Zejnullahu, K.2
Lindeman, N.3
-
44
-
-
0141497911
-
Depressionincancer: New developments regarding diagnosis and treatment
-
Raison CL, Miller AH. Depressionincancer: New developments regarding diagnosis and treatment. Biol Psychiatry 2003;54:283-294.
-
(2003)
Biol Psychiatry
, vol.54
, pp. 283-294
-
-
Raison, C.L.1
Miller, A.H.2
-
45
-
-
0030724718
-
Mechanisms of CNS response to systemic immune challenge: The febrile response
-
Elmquist JK, Scammell TE, Saper CB. Mechanisms of CNS response to systemic immune challenge: The febrile response. Trends Neurosci 1997; 12:565-570.
-
(1997)
Trends Neurosci
, vol.12
, pp. 565-570
-
-
Elmquist, J.K.1
Scammell, T.E.2
Saper, C.B.3
-
47
-
-
0029655626
-
Mechanisms of sickness-induced decreases in food-motivated behavior
-
Kent S, Bret-Dibat JL, Kelley KW et al. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci Biobehav Rev 1996;20: 171-175.
-
(1996)
Neurosci Biobehav Rev
, vol.20
, pp. 171-175
-
-
Kent, S.1
Bret-Dibat, J.L.2
Kelley, K.W.3
-
48
-
-
0031900680
-
Oncologists' recognition of depression in their patients with cancer
-
Passik SD, Dugan W, McDonald MV et al. Oncologists' recognition of depression in their patients with cancer. J Clin Oncol 1998;16:1594-1600.
-
(1998)
J Clin Oncol
, vol.16
, pp. 1594-1600
-
-
Passik, S.D.1
Dugan, W.2
McDonald, M.V.3
-
49
-
-
0032531710
-
How well do medical oncologists' perceptions reflect their patients' reported physical and psychoso-cial problems?
-
Newell S, Sanson-Fisher RW, Girgis A et al. How well do medical oncologists' perceptions reflect their patients' reported physical and psychoso-cial problems? Data from a survey of five oncologists. Cancer 1998;83: 1640-1651.
-
(1998)
Data from a survey of five oncologists. Cancer
, vol.83
, pp. 1640-1651
-
-
Newell, S.1
Sanson-Fisher, R.W.2
Girgis, A.3
-
50
-
-
9544247852
-
The effect of fluoxetine on anxiety and depression symptoms in cancer patients
-
Razavi D, Allilaire JF, Smith M et al. The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 1996; 94:205-210.
-
(1996)
Acta Psychiatr Scand
, vol.94
, pp. 205-210
-
-
Razavi, D.1
Allilaire, J.F.2
Smith, M.3
-
51
-
-
33644831732
-
A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression
-
Musselman DL, Somerset WI, Guo Y et al. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 2006;67:288-296.
-
(2006)
J Clin Psychiatry
, vol.67
, pp. 288-296
-
-
Musselman, D.L.1
Somerset, W.I.2
Guo, Y.3
-
52
-
-
34347270539
-
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: A placebo-controlled double-blind randomised trial
-
Stockler MR, O'Connell R, Nowak AK et al. Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: A placebo-controlled double-blind randomised trial. Lancet Oncol 2007;8:603-612.
-
(2007)
Lancet Oncol
, vol.8
, pp. 603-612
-
-
Stockler, M.R.1
O'Connell, R.2
Nowak, A.K.3
|